bpc 157 anti aging BPC157 and Anti-Aging Insights with Peter Attia BPC-157 Injectable Peptide for Healing

Psychiatry 170, 290-298 (2013)

PMC6073405 BPC-157 angiogenic signaling VEGFR2AkteNOS activation, nitric oxide bioavailability, FAK-paxillin cell-anchoring cascade, anti-cytokine modulation: PMC8275860 TB-4 / TB-500 G-actin sequestration and threshold-saturation mechanism actin-monomer binding, cytoskeletal mobilization for cell migration, mass-action pharmacodynamics requiring bolus dosing: PubMed 12581423 TB-4 Ac-SDKP anti-fibrotic fragment N-terminal tetrapeptide (fragment 14) released by meprin- and POP processing

The categories described in Section 2 are the categories we may have collected during the preceding 12 months

Published enforcement data from the FDAs drug safety communications show a significant increase in peptide-related enforcement actions between 2023 and 2025